Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM30JWZ)

Drug Name

SM04554 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Alopecia	ED70	Phase 2/3	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Wnt signaling pathway (Wnt pathway)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
SM-04690	DMOLTAD	Osteoarthritis	FA00-FA05	Phase 2	[3]
CWP232291	DMBUYIK	Acute myeloid leukaemia	2A60	Phase 1/2	[4]
SM08502	DM4KLNA	Solid tumour/cancer	2A00-2F9Z	Phase 1	[4]
SM04755	DM491NI	Liver cancer	2C12	Phase 1	[5]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Wnt signaling pathway (Wnt pathway)	TTFPSHI	NOUNIPROTAC	Modulator	[2]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT03742518) A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3	Clinical pipeline report, company report or official report of Phrma.org Arthritis 2014.
4	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
5	A Phase 1, Open-Label, Dose-Escalation, Dose-Finding Study Evaluating the Safety and Pharmacokinetics of SM04755 in Subjects with Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer.